Persistent elevation of plasma vitamin B12 is strongly associated with solid cancer

Valentin Lacombe(Université d'Angers), G. Urbanski(Centre Hospitalier Universitaire d'Angers), A. Ghali(Laboratoires d'Anjou (France)), Carole Lacout(Université d'Angers), Christian Lavigne(Université d'Angers), Olivier Capitain(Institut de Cancérologie de l'Ouest), Anne Patsouris(Institut de Cancérologie de l'Ouest), Floris Chabrun(Université d'Angers)

Scientific Reports

June 25, 2021

10.1038/s41598-021-92945-y

Cited by 54

Related Papers

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*

|British Journal of Dermatology|2021|414

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

|The Lancet Oncology|2021|231

Systemic and immune manifestations in myelodysplasia: A multicenter retrospective study

|Arthritis Care & Research|2011|97

The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome

|Journal of Translational Medicine|2023|71

Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry

|Annals of the Rheumatic Diseases|2023|70